NEW YORK--(BUSINESS WIRE)--Oct. 26, 2017--
Regulatory News:
Philip Morris International Inc. (NYSE/Euronext Paris: PM) informs its
shareholders that its Quarterly Report on Form 10-Q for the quarter
ended September 30, 2017 has been filed with the U.S. Securities and
Exchange Commission (“SEC”).
PMI makes available free of charge on its website at www.pmi.com,
its Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current
Reports on Form 8-K, reports filed pursuant to Section 16 of the U.S.
Securities Exchange Act of 1934 and amendments to those reports as soon
as reasonably practicable after PMI electronically files or furnishes
such materials to the SEC. All of these documents will be provided free
of charge to any shareholder requesting a copy by writing to: Philip
Morris International Inc., 120 Park Avenue, New York, New York 10017,
U.S.A., attention: Corporate Secretary. These documents are also
available on the SEC’s website at www.sec.gov.
About Philip Morris International Inc. (“PMI”)
PMI is a leading international tobacco company, with six of the world's
top 15 international brands and products sold in more than 180 markets.
In addition to the manufacture and sale of cigarettes, including Marlboro,
the number one global cigarette brand, and other tobacco products, PMI
is engaged in the development and commercialization of Reduced-Risk
Products (“RRPs”). RRPs is the term PMI uses to refer to products that
present, are likely to present, or have the potential to present less
risk of harm to smokers who switch to these products versus continued
smoking. Through multidisciplinary capabilities in product development,
state-of-the-art facilities, and industry-leading scientific
substantiation, PMI aims to provide an RRP portfolio that meets a broad
spectrum of adult smoker preferences and rigorous regulatory
requirements. For more information, see www.pmi.com
and www.pmiscience.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171026006050/en/
Source: Philip Morris International Inc.
Investor Relations:
New York: +1 (917) 663 2233
Lausanne: +41
(0)58 242 4666
or
Media:
Lausanne: +41 (0)58 242 4500